The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
The Cancer Worry Scale: Detecting Fear of Recurrence in Breast Cancer Survivors
Abstract
BACKGROUND: In 9% to 34% of cancer patients, the fear of cancer recurrence becomes so overwhelming that it affects quality of life. Clinicians need a brief questionnaire with a cutoff point that is able to differentiate between high- and low-fearful survivors. OBJECTIVE: This study investigated if the Cancer Worry Scale (CWS) could serve as an instrument to detect high levels of fear of recurrence in female breast cancer survivors. METHODS: One hundred ninety-four female breast cancer patients were assessed up to 11 years after their primary treatment for cancer. The women returned the questionnaires including the 8-item CWS, 2 items of the Cancer Acceptance Scale, the Checklist Individual Strength-Fatigue subscale, and the Cancer Empowerment Questionnaire. RESULTS: A cutoff score of 13 versus 14 (low: ≤13, high: ≥14) on the CWS was optimal for detecting severe levels of fear of recurrence. A cutoff score of 11 versus 12 (low: ≤11, high: ≥12) was optimal for screening. The Cronbach α coefficient of the CWS was .87; evidence to support the convergent and divergent validity of the CWS was also obtained. The CWS is able to detect high levels of fear of recurrence. CONCLUSION: The CWS is a reliable and valid questionnaire to assess fear of recurrence in breast cancer survivors. IMPLICATIONS FOR PRACTICE: With the CWS, it is possible for nurses to screen breast cancer survivors for severe levels of fear of cancer recurrence. Thereby, nurses can screen and assist survivors in accessing appropriate and available support.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychological empowerment: Issues and illustrations
Zimmerman, M. A. (1995) · American Journal of Community Psychology · doi:10.1007/bf02506983 · Cited by 2,317
The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment
Stanton, A. L., Danoff‐burg, S., & Huggins, M. E. (2002) · Psycho-Oncology · doi:10.1002/pon.574 · Cited by 545
Koch, L., Jansen, L., Brenner, H., & Arndt, V. (2013) · Psycho-Oncology · doi:10.1002/pon.3022 · Cited by 511
Deimling, G. T., Bowman, K. F., Sterns, S., Wagner, L. J., & Kahana, B. (2006) · Psycho-Oncology · doi:10.1002/pon.955 · Cited by 496
Vickberg, S. M. J. (2003) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm2501_03 · Cited by 468
Fear of cancer recurrence: a systematic literature review of self‐report measures
Thewes, B., Butow, P., Zachariae, R., Christensen, S., Simard, S., & Gotay, C. (2012) · Psycho-Oncology · doi:10.1002/pon.2070 · Cited by 262
Fear of cancer recurrence: specific profiles and nature of intrusive thoughts
Simard, S., Savard, J., & Ivers, H. (2010) · Journal of Cancer Survivorship · doi:10.1007/s11764-010-0136-8 · Cited by 229 · cited 1×
“Because of the variation in objective risk of recurrence among different cancer types, FCR is for some survivors more real and justified than for others, resulting in higher levels of fear.(6) It would be interesting to measure FCR in different cancer type populations and define cutoff points of the CWS for each type.”
Backgroundvan den Beuken‐van Everdingen, M. H. J., Peters, M. L., de Rijke, J. M., Schouten, H. C., van Kleef, M., & Patijn, J. (2008) · Psycho-Oncology · doi:10.1002/pon.1340 · Cited by 194 · cited 1×
“This fear can lead to problematic behaviors, including anxious preoccupations, avoidance, and excessive checking, contributing to an increased fear response.(10,16) Timely and adequate detection of high levels of FCR will be a first step toward treatment methods for FCR in order to improve the well-being of breast can…”
BackgroundFear of recurrence in long‐term testicular cancer survivors
Skaali, T., Fosså, S. D., Bremnes, R., Dahl, O., Haaland, C. F., Hauge, E. R., Klepp, O. N., Oldenburg, J., Wist, E., & Dahl, A. A. (2009) · Psycho-Oncology · doi:10.1002/pon.1437 · Cited by 180
Research works printed but not linked: 26
- Hodges, 2009, Fear of recurrence and psychological distress in head and neck cancer patients and their carers., Psychooncology, 18, 841, 10.1002/pon.1346 · DOI · Paper page
- Mehta, 2003, Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE., J Urol, 170, 1931, 10.1097/01.ju.0000091993.73842.9b · DOI
- Humphris, 2003, Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients., Int J Oral Maxillofac Surg, 32, 486, 10.1016/S0901-5027(03)90399-1 · DOI · Paper page
- Lee-Jones, 1997, Fear of cancer recurrencea literature review and proposed cognitive formulation to explain exacerbation of recurrence fears., Psychooncology, 6, 95, 10.1002/(SICI)1099-1611(199706)6:2<95::AID-PON250>3.0.CO;2-B · doi:10.1002/(sici)1099-1611(199706)6:2<95::aid-pon250>3.0.co;2-b
- Northouse, 1981, Mastectomy patients and the fear of cancer recurrence., Cancer Nurs, 4, 213, 10.1097/00002820-198106000-00004 · DOI · Paper page
- Mehnert, 2009, Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors., Psychooncology, 18, 1273, 10.1002/pon.1481 · DOI · Paper page
- Rogers, 2010, Fear of recurrence following head and neck cancer in the outpatient clinic., Eur Arch Otorhinolaryngol, 267, 1943, 10.1007/s00405-010-1307-y · DOI
- Gotay, 2007, Assessment of Survivor Concerns (ASC): a newly proposed brief questionnaire., Health Qual Life Outcomes, 5, 15, 10.1186/1477-7525-5-15 · DOI
- Douma, 2010, . Psychological distress and use of psychosocial support in familial adenomatous polyposis., Psychooncology, 19, 289, 10.1002/pon.1570 · DOI
- Lammens, 2010, . Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences., JCO, 28, 3008, 10.1200/JCO.2009.27.2112 · DOI
- Lammens, 2010, . Psychosocial impact of von Hippel-Lindau disease: levels and sources of distress., Clin Genet, 77, 483, 10.1111/j.1399-0004.2010.01333.x · DOI
- Gielissen, 2007, The experience of severe fatigue in long term survivors of stem cell transplantation., Bone Marrow Transplant, 39, 595, 10.1038/sj.bmt.1705624 · DOI · Paper page
- Lerman, 1991, Psychological and behavioral implications of abnormal mammograms., Ann Intern Med, 114, 657, 10.7326/0003-4819-114-8-657 · DOI · Paper page
- Lerman, 1994, Attitudes about genetic testing for breast ovarian cancer susceptibility., J Clin Oncol, 12, 843, 10.1200/JCO.1994.12.4.843 · DOI · Paper page
- Lerman, 1994, Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior., J Natl Cancer Inst Monogr, 16, 171
- Watson, 1998, Walsh MW, et al.., Family history of breast cancer: what do women understand and recall about their genetic risk J Med Genet, 35, 731
- Hopwood, 2001, Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer., J Med Genet, 38, 139, 10.1136/jmg.38.2.139 · DOI
- Servaes, 2003, Fatigue after treatment for malignant and benign bone and soft tissue tumors., J Pain Symptom Manage, 26, 1113, 10.1016/j.jpainsymman.2003.03.001 · DOI
- Van den Berg, 2010, Validation of an Empowerment Questionnaire in breast cancer survivors., Psychooncology, 19, S88
- Beurskens, 2000, Fatigue among working people: validity of a questionnaire measure., Occup Environ Med, 57, 353, 10.1136/oem.57.5.353 · DOI · Paper page
- Dittner, 2004, The assessment of fatiguea practical guide for clinicians and researchers., J Psychosom Res, 56, 157, 10.1016/S0022-3999(03)00371-4 · DOI · Paper page
- Vercoulen, 1994, Dimensional assessment of chronic fatigue syndrome., J Psychosom Res, 38, 383, 10.1016/0022-3999(94)90099-X · DOI · Paper page
- Servaes, 2002, Fatigue after breast cancer and in chronic fatigue syndrome: similarities and differences., J Psychosom Res, 52, 453, 10.1016/S0022-3999(02)00300-8 · DOI
- Weintraub, 2006, Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease., Am J Geriatr Psychiatry, 14, 169, 10.1097/01.JGP.0000192488.66049.4b · DOI · Paper page
- Henselmans, 2010, Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis., Health Psychol, 29, 160, 10.1037/a0017806 · DOI · Paper page
- Hinnen, 2008, Course of distress in breast cancer patients, their partners, and matched control couples., Ann Behav Med, 36, 141, 10.1007/s12160-008-9061-8 · DOI
Cited by
Follow-up strategies for patients treated for non-metastatic colorectal cancer
Jeffery, M., Hickey, B. E., Hider, P. N., & See, A. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002200.pub3 · Cited by 640
Screening and comorbidity of clinical levels of fear of cancer recurrence
Simard, S., & Savard, J. (2015) · Journal of Cancer Survivorship · doi:10.1007/s11764-015-0424-4 · Cited by 329
van de Wal, M., Thewes, B., Gielissen, M., Speckens, A., & Prins, J. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.5301 · Cited by 195
Self-citationvan den Berg, S. W., Gielissen, M. F. M., Custers, J. A. E., van der Graaf, W. T. A., Ottevanger, P. B., & Prins, J. B. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.9386 · Cited by 201
Self-citationYang, Y., Li, W., Wen, Y., Wang, H., Sun, H., Liang, W., Zhang, B., & Humphris, G. (2019) · Psycho-Oncology · doi:10.1002/pon.5013 · Cited by 121
Metadata
- Authors
- Custers, J. A. E., van den Berg, S. W., van Laarhoven, H. W. M., Bleiker, E. M. A., Gielissen, M. F. M., & Prins, J. B.
- Venue
- Cancer Nursing
- Published
- 2014-01
- Volume
- 37
- Issue
- 1
- Pages
- E44-E50
- ISSN
- 0162-220X (ISSN-L)
- OpenAlex
- W2046736751
- Cited by
- 243
- References
- 9
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Cancer Worry Scale: Detecting Fear of Recurrence in Breast Cancer Survivors. https://app.cochat.ai/papers/10.1097/ncc.0b013e3182813a17
- The paper
- Custers, J. A. E., van den Berg, S. W., van Laarhoven, H. W. M., Bleiker, E. M. A., Gielissen, M. F. M., & Prins, J. B. (2014). The Cancer Worry Scale: Detecting Fear of Recurrence in Breast Cancer Survivors. Cancer Nursing. https://doi.org/10.1097/ncc.0b013e3182813a17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.